Maccura Biotechnology (China) Today
| 300463 Stock | 14.01 0.17 1.23% |
Performance8 of 100
| Odds Of DistressLess than 2
|
Maccura Biotechnology is trading at 14.01 as of the 26th of November 2024, a 1.23 percent increase since the beginning of the trading day. The stock's open price was 13.84. Maccura Biotechnology has a very small chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Maccura Biotechnology Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2024 and ending today, the 26th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Maccura Biotechnology is entity of China. It is traded as Stock on SHE exchange. The company has 612.47 M outstanding shares. More on Maccura Biotechnology Co
Moving together with Maccura Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Maccura Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Maccura Biotechnology's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Maccura Biotechnology or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Biotech (View all Themes) | ||||
| Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Biotech, Health Care, Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Maccura Biotechnology's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Maccura Biotechnology's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsMaccura Biotechnology can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Maccura Biotechnology's financial leverage. It provides some insight into what part of Maccura Biotechnology's total assets is financed by creditors.
| |||||
Maccura Biotechnology Co (300463) is traded on Shenzhen Stock Exchange in China and employs 3,362 people. Maccura Biotechnology is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.48 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Maccura Biotechnology's market, we take the total number of its shares issued and multiply it by Maccura Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Maccura Biotechnology operates under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 612.47 M outstanding shares.
Maccura Biotechnology generates positive cash flow from operations, but has no cash available
Check Maccura Biotechnology Probability Of Bankruptcy
Ownership AllocationMaccura Biotechnology maintains a total of 612.47 Million outstanding shares. Maccura Biotechnology Co holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Maccura Ownership Details
Maccura Biotechnology Risk Profiles
Although Maccura Biotechnology's alpha and beta are two of the key measurements used to evaluate Maccura Biotechnology's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.22 | |||
| Semi Deviation | 2.42 | |||
| Standard Deviation | 3.27 | |||
| Variance | 10.66 |
Maccura Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Maccura Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Maccura Biotechnology Corporate Directors
| Shengguo Xu | Director Director | Profile | |
| Wu Mingjian | GM Director | Profile | |
| Hui Yang | Director Reagents | Profile | |
| Zhen Wang | Production Director | Profile |
Other Information on Investing in Maccura Stock
Maccura Biotechnology financial ratios help investors to determine whether Maccura Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Maccura with respect to the benefits of owning Maccura Biotechnology security.